VeriMomhexapeptide-12 é seguro durante a gravidez?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
Pregnancy-safe products containing hexapeptide-12
Related ingredients
Frequently asked questions
- hexapeptide-12 é seguro durante a gravidez?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
- hexapeptide-12 é seguro durante a amamentação?
- No data indicating reproductive or lactation toxicity, no mechanistic evidence for transfer into breastmilk, and no harmonised classifications. With no demonstrated systemic bioavailability from topical use, breastfeeding exposure is considered negligible. Sources: SCCS/CIR (no opinion), PubMed (no lactation studies), PubChem/CosIng (no hazard data).
- hexapeptide-12 é seguro para a pele do bebê?
- No infant-specific toxicity or developmental data identified. Hazard and mechanism remain 0 due to lack of evidence or harmonised classification. Dermal exposure score increased by +1 for baby skin (to 1) because peptides are not completely non‑absorbable and infant skin has a higher surface-area-to-weight ratio and immature barrier, so a low but measurable exposure is plausible even if adult absorption is negligible. Sources: general dermal absorption principles (peptide physicochemistry), CosIng/PubChem (ingredient listings), PubMed (no infant studies).
- Como o VeriMom pontua hexapeptide-12?
- O VeriMom pontua hexapeptide-12 em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a hexapeptide-12 na gravidez?
- Veja nossa lista curada de alternativas seguras a hexapeptide-12 com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.